Thus, our study showed that VDAC1 depletion represents a trigger for reprograming malignant cancer cells into a post-mitotic state and probably into terminally differentiated cells and that this might be a promising therapeutic approach for various cancers. This evidence concerns the gene VDAC1 and cancer.